Bhim Bahadur Raiمشاهده پروفایل
پژوهشگر ارشد
Dr. Bhim Bahadur Rai is a Research Fellow at the John Curtin School of Medical Research (JCSMR), Australian National University, and an Associate Professor of Ophthalmology at the Postgraduate Medical Education Centre, University Medical Sciences of Bhutan. With over 15 years of clinical experience as an ophthalmologist and vitreoretinal surgeon across Bhutan, India, and Nepal, he pioneered national eye care programs including Bhutan's Diabetic Retinopathy Screening and Retinopathy of Prematurity initiatives while introducing advanced technologies like phaco-emulsification cataract surgery and laser retinal therapies. His educational background includes: MBBS and postgraduate ophthalmology training from India Medical retina fellowship from the USA Surgical retina fellowship from Nepal PhD from Australian National University under Prof. Ted Maddess Dr. Rai's research centers on objective diagnostic methodologies for retinal and neurological conditions, with emphasis on diabetic eye diseases , age-related macular degeneration , glaucoma , and neurodegenerative disorders like Alzheimer's and multiple sclerosis. His work integrates pupillography-based visual field testing to develop non-invasive diagnostic tools applicable in resource-limited settings, bridging clinical practice with translational innovation for early disease detection and public health implementation. Analysis of his recent publications reveals a cohesive research trajectory focused on validating objective perimetry across diverse pathologies—from diabetic retinopathy to concussion injuries—with strong translational emphasis on adapting diagnostics for national screening programs and personalized medicine in metabolic and neurological disorders. Professional recognitions include: Fellow of the Higher Education Academy (FHEA) VitreoRetinal Fellowship (VR Fellow) As a registered research supervisor, Dr. Rai contributes to major initiatives including the ANU-funded "Refining the ObjectiveFIELD Analyser" project (2022-2025) targeting diabetes and neuro-ophthalmic diseases, the multi-center FAME 1 study on fenofibrate therapy, and the "Our Health in Our Hands" grand challenge initiative. His grant portfolio demonstrates strategic focus on developing accessible diagnostic technologies for global health applications. Dr. Rai operates within the Maddess Group (Diagnostics for Eye Diseases) at JCSMR's Neuroscience Eccles Institute, where his team pioneers pupillography-based visual field analyzers with cross-disease applications spanning diabetic complications, neurodegenerative conditions, and public health screening infrastructure.





